After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics episode artwork

EPISODE · May 31, 2016 · 40 MIN

After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

from Medsider: Learn from Medtech and Healthtech Founders and CEOs · host Scott Nelson

Jack Dorsey received quite a bit of attention when he was recently announced as CEO of Twitter. Why? Because that made him CEO of 2 of the most rapidly-growing tech. companies in Silicon Valley at the same – Twitter and Square. Well, medtech’s version ...

Episode metadata supplied by the publisher feed · Published May 31, 2016

Embed this episode

Ready to play

After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics

0:00 40:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medsider: Learn from Medtech and Healthtech Founders and CEOs?

This episode is 40 minutes long.

When was this Medsider: Learn from Medtech and Healthtech Founders and CEOs episode published?

This episode was published on May 31, 2016.

Can I download this Medsider: Learn from Medtech and Healthtech Founders and CEOs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!